Our team members have lead a number of cases in the area of healthcare and pharmaceuticals. In 2006 they have advised Warburg Pincus in assessing M&A targets.
In 2012-13 our team members led advisory project for Gemotest, the second largest private lab testing Company aimed at attracting growth financing and assessing the alternatives.
Our team members have also helped a number of Western leaders in pharma to analyse acquisition targets.
In 2012-13 our team members led advisory project for Gemotest, the second largest private lab testing Company aimed at attracting growth financing and assessing the alternatives.
Our team members have also helped a number of Western leaders in pharma to analyse acquisition targets.